Tratamento
Brazil's ANVISA just approved a second generic semaglutide, opening the door to more competition and potentially lower prices for GLP-1 medications. Here's what to expect.
Eurofarma announced a significant price reduction for its semaglutide treatment Poviztra, potentially expanding access to GLP-1 therapy for Brazilian patients who previously faced high costs.
Can temperature fluctuations ruin your GLP-1 weight loss pen during long trips? Here's what the stability data says about storing Ozempic, Mounjaro, and similar medications while traveling.
Brazil's medical council issued guidance targeting compounded GLP-1 drugs for weight loss. Here's what patients and doctors need to understand about the controversy.
Brazilian patients seeking tirzepatide face a frustrating reality: neighboring countries have found ways to make this medication accessible, while Brazil's regulatory landscape leaves patients without legal access.
Wondering when you might need to pause your semaglutide treatment and what happens to your body during a break? Here's what the medical evidence shows.
Tirzepatide often produces noticeable weight changes within the first few weeks of treatment. Understanding why this happens can help you set realistic expectations and stay motivated throughout your journey.
